US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.640
  • -0.020-1.20%
Close Mar 28 16:00 ET
  • 1.640
  • 0.0000.00%
Post 19:31 ET
58.86MMarket Cap-0.80P/E (TTM)

Immuneering Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.32%-55M
-23.23%-14.51M
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
-11.04%-48.97M
-0.23%-11.78M
-13.22%-12.03M
-13.75%-10.75M
-17.40%-14.42M
Net income from continuing operations
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
Operating gains losses
72.23%6.78K
122.68%5.47K
----
----
----
-23.81%3.94K
--2.46K
--0
--817
--666
Depreciation and amortization
9.37%385.07K
-3.75%93.43K
12.45%96.27K
14.37%97.85K
16.32%97.53K
26.99%352.08K
15.32%97.07K
13.56%85.61K
203.15%85.56K
-58.21%83.84K
Change In working capital
5.05%-925.38K
-10.19%1.69M
17.25%-657.59K
2,577.24%724.49K
-28.38%-2.68M
-156.76%-974.64K
297.65%1.88M
-175.85%-794.68K
-96.54%27.06K
-256.48%-2.09M
-Change in receivables
--0
--0
--0
--0
--0
-94.69%12.42K
--0
--0
-98.97%1.05K
133.87%11.37K
-Change in prepaid assets
85.60%-24.87K
2,862.75%1.16M
21.25%-644.55K
-550.66%-788.13K
-51.47%248.9K
39.28%-172.66K
90.69%-41.95K
55.99%-818.49K
-71.67%174.88K
-63.60%512.9K
-Change in payables and accrued expense
18.69%-312.97K
-79.35%437.05K
117.96%156.22K
3,644.43%1.74M
-4.79%-2.65M
-117.22%-384.91K
133.84%2.12M
-97.77%71.68K
-146.39%-49.06K
-27.02%-2.52M
-Change in other current assets
10.11%-261.34K
--0
---67.69K
---223.64K
--30K
19.28%-290.74K
-7,020.79%-290.74K
--0
--0
--0
-Change in other current liabilities
-135.11%-326.21K
-3.75%95.84K
-112.21%-101.57K
97.36%-2.64K
-250.60%-317.84K
-30.18%-138.75K
389.22%99.58K
-10.99%-47.87K
-138.26%-99.81K
-804.94%-90.66K
Cash from discontinued investing activities
Operating cash flow
-12.32%-55M
-23.23%-14.51M
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
-11.04%-48.97M
-0.23%-11.78M
-13.22%-12.03M
-13.75%-10.75M
-17.40%-14.42M
Investing cash flow
Cash flow from continuing investing activities
262.30%26.43M
75.26%5.49M
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
-82.56%7.3M
-61.57%3.13M
-2,623.83%-23.97M
-58.64%9.16M
52.94%18.97M
Net PPE purchase and sale
75.24%-84.88K
94.53%-9.36K
90.78%-5.27K
62.19%-32.77K
-33.88%-37.48K
53.84%-342.75K
-146.63%-170.92K
85.46%-57.15K
47.46%-86.69K
75.67%-27.99K
Net investment purchase and sale
247.15%26.52M
66.47%5.5M
77.38%-5.41M
-45.95%5M
12.79%21.43M
-82.06%7.64M
-59.82%3.3M
-4,811.18%-23.91M
-58.56%9.25M
51.76%19M
Cash from discontinued investing activities
Investing cash flow
262.30%26.43M
75.26%5.49M
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
-82.56%7.3M
-61.57%3.13M
-2,623.83%-23.97M
-58.64%9.16M
52.94%18.97M
Financing cash flow
Cash flow from continuing financing activities
-81.35%5.3M
-623.14%-40.99K
20,249.61%4.36M
0
309.31%979.92K
149,558.35%28.44M
104.24%7.84K
224.60%21.45K
101,297.86%28.17M
23.97%239.41K
Net common stock issuance
-84.97%4.24M
--0
--4.24M
----
----
--28.2M
--0
--0
----
----
Proceeds from stock option exercised by employees
148.88%1.11M
--0
493.00%127.19K
--0
309.31%979.92K
48.09%444.84K
-81.39%7.84K
-42.63%21.45K
533.99%176.15K
23.97%239.41K
Net other financing activities
79.88%-40.99K
----
----
----
----
27.58%-203.77K
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-81.35%5.3M
-623.14%-40.99K
20,249.61%4.36M
--0
309.31%979.92K
149,558.35%28.44M
104.24%7.84K
224.60%21.45K
101,297.86%28.17M
23.97%239.41K
Net cash flow
Beginning cash position
-18.22%59.41M
-33.56%45.21M
-42.58%59.73M
-14.39%66.29M
-18.22%59.41M
-3.01%72.64M
-10.96%68.04M
18.29%104.02M
2.96%77.43M
-3.01%72.64M
Current changes in cash
-75.81%-23.26M
-4.94%-9.06M
59.63%-14.52M
-124.67%-6.56M
43.56%6.88M
-487.72%-13.23M
-128.37%-8.63M
-212.31%-35.98M
108.82%26.59M
1,412.52%4.79M
End cash Position
-39.16%36.14M
-39.16%36.14M
-33.56%45.21M
-42.58%59.73M
-14.39%66.29M
-18.22%59.41M
-18.22%59.41M
-10.96%68.04M
18.29%104.02M
2.96%77.43M
Free cash flow
-11.71%-55.08M
-21.54%-14.52M
-11.53%-13.48M
-6.68%-11.56M
-7.49%-15.53M
-9.96%-49.31M
-1.08%-11.95M
-9.70%-12.08M
-12.70%-10.84M
-16.54%-14.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.32%-55M-23.23%-14.51M-12.02%-13.47M-7.23%-11.53M-7.44%-15.49M-11.04%-48.97M-0.23%-11.78M-13.22%-12.03M-13.75%-10.75M-17.40%-14.42M
Net income from continuing operations -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M
Operating gains losses 72.23%6.78K122.68%5.47K-------------23.81%3.94K--2.46K--0--817--666
Depreciation and amortization 9.37%385.07K-3.75%93.43K12.45%96.27K14.37%97.85K16.32%97.53K26.99%352.08K15.32%97.07K13.56%85.61K203.15%85.56K-58.21%83.84K
Change In working capital 5.05%-925.38K-10.19%1.69M17.25%-657.59K2,577.24%724.49K-28.38%-2.68M-156.76%-974.64K297.65%1.88M-175.85%-794.68K-96.54%27.06K-256.48%-2.09M
-Change in receivables --0--0--0--0--0-94.69%12.42K--0--0-98.97%1.05K133.87%11.37K
-Change in prepaid assets 85.60%-24.87K2,862.75%1.16M21.25%-644.55K-550.66%-788.13K-51.47%248.9K39.28%-172.66K90.69%-41.95K55.99%-818.49K-71.67%174.88K-63.60%512.9K
-Change in payables and accrued expense 18.69%-312.97K-79.35%437.05K117.96%156.22K3,644.43%1.74M-4.79%-2.65M-117.22%-384.91K133.84%2.12M-97.77%71.68K-146.39%-49.06K-27.02%-2.52M
-Change in other current assets 10.11%-261.34K--0---67.69K---223.64K--30K19.28%-290.74K-7,020.79%-290.74K--0--0--0
-Change in other current liabilities -135.11%-326.21K-3.75%95.84K-112.21%-101.57K97.36%-2.64K-250.60%-317.84K-30.18%-138.75K389.22%99.58K-10.99%-47.87K-138.26%-99.81K-804.94%-90.66K
Cash from discontinued investing activities
Operating cash flow -12.32%-55M-23.23%-14.51M-12.02%-13.47M-7.23%-11.53M-7.44%-15.49M-11.04%-48.97M-0.23%-11.78M-13.22%-12.03M-13.75%-10.75M-17.40%-14.42M
Investing cash flow
Cash flow from continuing investing activities 262.30%26.43M75.26%5.49M77.41%-5.42M-45.79%4.97M12.76%21.39M-82.56%7.3M-61.57%3.13M-2,623.83%-23.97M-58.64%9.16M52.94%18.97M
Net PPE purchase and sale 75.24%-84.88K94.53%-9.36K90.78%-5.27K62.19%-32.77K-33.88%-37.48K53.84%-342.75K-146.63%-170.92K85.46%-57.15K47.46%-86.69K75.67%-27.99K
Net investment purchase and sale 247.15%26.52M66.47%5.5M77.38%-5.41M-45.95%5M12.79%21.43M-82.06%7.64M-59.82%3.3M-4,811.18%-23.91M-58.56%9.25M51.76%19M
Cash from discontinued investing activities
Investing cash flow 262.30%26.43M75.26%5.49M77.41%-5.42M-45.79%4.97M12.76%21.39M-82.56%7.3M-61.57%3.13M-2,623.83%-23.97M-58.64%9.16M52.94%18.97M
Financing cash flow
Cash flow from continuing financing activities -81.35%5.3M-623.14%-40.99K20,249.61%4.36M0309.31%979.92K149,558.35%28.44M104.24%7.84K224.60%21.45K101,297.86%28.17M23.97%239.41K
Net common stock issuance -84.97%4.24M--0--4.24M----------28.2M--0--0--------
Proceeds from stock option exercised by employees 148.88%1.11M--0493.00%127.19K--0309.31%979.92K48.09%444.84K-81.39%7.84K-42.63%21.45K533.99%176.15K23.97%239.41K
Net other financing activities 79.88%-40.99K----------------27.58%-203.77K--0--0--------
Cash from discontinued financing activities
Financing cash flow -81.35%5.3M-623.14%-40.99K20,249.61%4.36M--0309.31%979.92K149,558.35%28.44M104.24%7.84K224.60%21.45K101,297.86%28.17M23.97%239.41K
Net cash flow
Beginning cash position -18.22%59.41M-33.56%45.21M-42.58%59.73M-14.39%66.29M-18.22%59.41M-3.01%72.64M-10.96%68.04M18.29%104.02M2.96%77.43M-3.01%72.64M
Current changes in cash -75.81%-23.26M-4.94%-9.06M59.63%-14.52M-124.67%-6.56M43.56%6.88M-487.72%-13.23M-128.37%-8.63M-212.31%-35.98M108.82%26.59M1,412.52%4.79M
End cash Position -39.16%36.14M-39.16%36.14M-33.56%45.21M-42.58%59.73M-14.39%66.29M-18.22%59.41M-18.22%59.41M-10.96%68.04M18.29%104.02M2.96%77.43M
Free cash flow -11.71%-55.08M-21.54%-14.52M-11.53%-13.48M-6.68%-11.56M-7.49%-15.53M-9.96%-49.31M-1.08%-11.95M-9.70%-12.08M-12.70%-10.84M-16.54%-14.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More